Biotech Startups

Telomere Therapeutics is a gene therapy company developing treatments that repair telomeres to address organ fibrosis and telomere-dysfunction syndromes. Its lead program is an AAV-based therapy for idiopathic pulmonary fibrosis (IPF).

1 investor

Tempo Therapeutics is a biotechnology company developing therapeutics, with a focus that includes dermatology. Its team works on a pipeline built around its underlying technology platform.

1 investor

Temprian Oncology develops nanoparticle-based "Supercarriers" that deliver a prodrug toxic to melanoma cells, releasing the active ingredient inside metastatic melanoma tumor cells in low-pH pigment-making organelles. The therapy targets late-stage, metastasized melanoma and is designed to work alongside or replace existing TKI and immune checkpoint inhibitor treatments.

1 investor

Temprian Therapeutics is a biopharmaceutical company developing an HSP70i-based immunotherapy for vitiligo. It focuses on advancing a treatment for pigmentation disorders through clinical development.

1 investor

Ten Lives Foods makes sustainable, lab-brewed protein snacks for cats, offering lickable treats produced without using animal-derived ingredients. The company aims to reduce pet-driven meat consumption and its associated environmental impact.

1 investor

IBSRELA is a prescription medication containing tenapanor designed to treat irritable bowel syndrome with constipation (IBS-C) in adults by reducing constipation and abdominal pain. The drug works by increasing intestinal water retention, supporting gut lining integrity, and reducing pain-sensing nerve sensitivity.

1 investor

Tenax Therapeutics is a clinical-stage pharmaceutical company developing TNX-103, an oral formulation of the drug levosimendan, to treat pulmonary hypertension resulting from heart failure with preserved ejection fraction (PH-HFpEF). The company focuses on this cardiovascular and pulmonary disease, which currently has no approved treatments.

1 investor

Tenboron develops boron carriers for boron neutron capture therapy (BNCT), a form of targeted radiation treatment for cancer. The company creates regulatory-approved pharmaceutical compounds to be used with accelerator-based neutron sources in clinical oncology.

1 investor

Tend develops therapeutic solutions and diagnostic tools focused on the gut microbiome to treat chronic intestinal and digestive health conditions. The company serves researchers, clinicians, and patients seeking evidence-based alternatives to traditional disease management approaches.

1 investor

Tenmile is an Australian health technology venture capital firm that funds and supports early-stage biotech and medtech innovations with the goal of bringing Australian research breakthroughs to global markets. Beyond capital, the firm provides portfolio companies with talent recruitment support, international partnerships, and regulatory guidance.

1 investor

Tensegrity Pharma develops early-stage clinical development programs and drug discovery services for the pharmaceutical industry. The company leverages a network of investigators, contract research organizations, and key opinion leaders to support new drug programs.

1 investor

Tensive is a clinical-stage medical device company developing REGENERA™/SOFTAG™ resorbable biopolymer scaffolds for natural breast reconstruction and tissue marking following lumpectomy. It serves breast cancer patients and surgeons, working in the advanced biomaterials and medical device field.

1 investor

Ritivel builds an AI-native platform that automates regulatory workflows and documentation for life sciences companies, helping accelerate the submission of therapies to patients.

1 investor

Tentarix Biotherapeutics develops multifunctional biologics to modernize healthcare standards through precision medicine. The company focuses on biologic drug development and innovation in the therapeutic sector.

1 investor

Creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology.

1 investor

TeraPore develops nanofiltration products based on tunable self-assembled block copolymer technology to address complex separation challenges in biopharmaceutical production and semiconductor manufacturing. The company serves customers in human health and high-performance computing applications and is based in the San Francisco Bay area.

1 investor

Terrabiom works on soil restoration by reestablishing microbial communities (mycorrhizal fungi and bacteria) so that native vegetation can take root and self-sustaining forest ecosystems can regenerate. It focuses on reforestation and ecological restoration of degraded soils, including native species such as ñirre, notro, lenga, canelo, coigüe, alerce, and araucaria.

1 investor

Terragia develops consolidated bioprocessing technology using engineered thermophilic bacteria to convert cellulosic biomass, such as crop residues and perennial crops, into ethanol, other biofuels, and co-products at costs competitive with petroleum. Its technology targets low-carbon liquid fuels for hard-to-electrify transportation modes like aviation, marine, and long-haul trucking.

1 investor

Terrana Biosciences is an agricultural biotech company applying RNA technology to plant health, developing a platform that gives crops new traits such as drought tolerance and shorter ripening times. The company works on RNA-based solutions for agriculture and was built out of Flagship Pioneering's RNA expertise.

1 investor

Terrapeutics operates a drug discovery platform that screens natural compounds produced by soil microorganisms to find molecules targeting "undruggable" disease targets such as protein-protein interactions and transcription factors. The company currently focuses on RAS inhibitors and infectious diseases, aiming at hard-to-treat conditions including cancer.

1 investor

Terumo Medical Corporation manufactures medical devices and healthcare products across four divisions, including interventional systems for vascular access, injection and infusion devices, drug delivery devices, and precision medicine software and care pathway consulting. It serves healthcare providers as a subsidiary of Terumo Corporation.

1 investor

Tesabio.ai is a platform that uses AI to identify small molecules capable of rebalancing dysregulated microRNA networks in complex diseases by optimizing for whole-network restoration rather than single-target approaches. The platform serves biotech and pharmaceutical companies developing novel therapeutics across disease indications.

1 investor

TesoRx Pharma is a biopharmaceutical company that develops and launches drug products using formulations such as tablets, capsules, injectables, oral formulations, ointments, creams, and nasal drug delivery systems. Its leadership focuses on therapeutic areas including dermatology, urology, oncology, and ophthalmology.

1 investor

Tessellate Bio is a biotech company researching synthetic lethal interactions beyond Homologous Recombination Deficiency (HRD) to build a pipeline of first-in-class precision medicines. It focuses on discovering novel cancer biology to address unmet patient needs.

1 investor